(RTTNews) - Polyrizon Ltd. (PLRZ), a biotechnology company developing intranasal products, reported encouraging preclinical findings showing that its proprietary Trap and Target naloxone hydrogel ...
Ra’anana, Israel, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a biotechnology company focusing on the development of intranasal products, today ...
Polyrizon Ltd. (NASDAQ: PLRZ) stock traded sharply higher Thursday as volume spiked to 18.56 million shares, well above the typical 2.62 million average, Benzinga Pro data showed. Polyrizon on ...
RA’ANANA, Israel - Polyrizon Ltd. (NASDAQ:PLRZ) announced Wednesday that its experimental naloxone hydrogel demonstrated superior mucoadhesion compared to a marketed intranasal naloxone spray in ...
Looking to improve drug product effectiveness and differentiate? Mucoadhesion – the ability of a formulation to adhere to a mucous membrane – is an attractive option for those keen to ensure their ...
Learn about the biggest trends impacting oral and topical drug delivery and how these trends are impacting the excipient sector. Additionally, learn more about mucoadhesion and ...
Superior Mucoadhesion may potentially Translate into More Reliable Opioid Overdose Reversal in Real-World Emergencies Ra'anana, Israel, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results